SEC 13F Intelligence

Orbimed Advisors LLC / EWTX

Orbimed Advisors LLC’s Edgewise Therapeutics Inc Position

Does Orbimed Advisors LLC own Edgewise Therapeutics Inc (EWTX)? Yes — 15.52M shares worth $489M (+9.69% of its 13F portfolio) as of Q1 2026.

Position Value
$489M
Q1 2026
Shares
15.52M
% of Portfolio
+9.69%
Quarters Held
21
currently held

Position History EWTX

Reported value by quarter
Q1 ’21: $453MQ1 ’21Q2 ’21: $297MQ3 ’21: $231MQ4 ’21: $213MQ4 ’21Q1 ’22: $135MQ2 ’22: $112MQ3 ’22: $143MQ3 ’22Q4 ’22: $130MQ1 ’23: $97MQ2 ’23: $113MQ2 ’23Q3 ’23: $83MQ4 ’23: $159MQ1 ’24: $274MQ1 ’24Q2 ’24: $271MQ3 ’24: $401MQ4 ’24: $401MQ4 ’24Q1 ’25: $330MQ2 ’25: $203MQ3 ’25: $252MQ3 ’25Q4 ’25: $385MQ1 ’26: $489Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202615.52M$489M+9.69%
Q4 202515.52M$385M+7.86%
Q3 202515.52M$252M+5.92%
Q2 202515.52M$203M+5.08%
Q1 202515.02M$330M+7.88%
Q4 202415.02M$401M+8.25%
Q3 202415.02M$401M+7.28%
Q2 202415.02M$271M+5.34%
Q1 202415.02M$274M+5.02%
Q4 202314.57M$159M+3.18%
Q3 202314.57M$83M+1.77%
Q2 202314.57M$113M+2.05%
Q1 202314.57M$97M+1.91%
Q4 202214.57M$130M+2.49%
Q3 202214.57M$143M+2.66%
Q2 202214.08M$112M+2.03%
Q1 202213.94M$135M+2.19%
Q4 202113.94M$213M+2.74%
Q3 202113.94M$231M+2.54%
Q2 202113.94M$297M+3.01%
Q1 202113.94M$453M+4.24%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of EWTX.